Effectiveness, safety and potential predictors of response at week 16 in patients with severe hidradenitis suppurativa treated with secukinumab: A multicenter observational retrospective study

被引：0

作者：

Serrano, Pablo Fernandez-Crehuet ^{[3
,4
]}

Haselgruber-deFrancisco, Sofia ^{[1
]}

Padial-Gomez, Alicia ^{[5
]}

Vasquez-Chinchay, Fiorella ^{[6
]}

Fernandez-Ballesteros, Maria D. ^{[7
]}

Lopez-Riquelme, Irene ^{[7
]}

Jimenez-Gallo, David ^{[8
]}

Segura-Palacios, Juan M. ^{[9
]}

Contreras-Steyls, Marisol ^{[10
]}

Osorio-Gomez, Guiovana F. ^{[11
]}

Hernandez-Rodriguez, Juan Carlos ^{[11
]}

Cuenca-Barrales, Carlos ^{[1
]}

Molina-Leyva, Alejandro ^{[1
,2
]}

机构：

[1] Hosp Univ Virgen de las Nieves, IBS Granada, Hidradenitis Suppurativa Clin, Granada, Spain

[2] European Hidradenitis Suppurativa Fdn, Dessau Rosslau, Germany

[3] Hosp Reina Sofia Cordoba, Cordoba, Spain

[4] IMIBIC, Dept Dermatol, Cordoba, Spain

[5] Hosp Univ Jerez de la Frontera, Dept Dermatol, Jerez de la Frontera, Spain

[6] Hosp Univ Virgen Valme, Dept Dermatol, Seville, Spain

[7] Hosp Univ Reg Malaga, Dept Dermatol, Malaga, Spain

[8] Hosp Univ Puerta Mar, Dept Dermatol, Cadiz, Spain

[9] Hosp Costa Sol, Dept Dermatol, Marbella, Spain

[10] Hosp Univ Virgen de la Victoria, Dept Dermatol, Malaga, Spain

[11] Hosp Univ Virgen de Rocio, Dept Dermatol, Seville, Spain

来源：

EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：108 / 108

页数：1

共 50 条

[1] Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study
Fernandez-Crehuet, Pablo
Haselgruber, Sofia
Padial-Gomez, Alicia
Vasquez-Chinchay, Fiorella
Fernandez-Ballesteros, Maria Dolores
Lopez-Riquelme, Irene
Jimenez-Gallo, David
Segura-Palacios, Juan Manuel
Contreras-Steyls, Marisol
Osorio-Gomez, Giovana Fernanda
Hernandez-Rodriguez, Juan Carlos
Sanchez-Diaz, Manuel
Cuenca-Barrales, Carlos
Arias-Santiago, Salvador
Molina-Leyva, Alejandro
DERMATOLOGY AND THERAPY, 2023, 13 (04) : 1029 - 1038
[2] Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study
Pablo Fernandez-Crehuet
Sofía Haselgruber
Alicia Padial-Gomez
Fiorella Vasquez-Chinchay
Maria Dolores Fernandez-Ballesteros
Irene López-Riquelme
David Jimenez-Gallo
Juan Manuel Segura-Palacios
Marisol Contreras-Steyls
Giovana Fernanda Osorio-Gómez
Juan Carlos Hernández-Rodríguez
Manuel Sanchez-Diaz
Carlos Cuenca-Barrales
Salvador Arias-Santiago
Alejandro Molina-Leyva
Dermatology and Therapy, 2023, 13 (4) : 1029 - 1038
[3] Effectiveness and safety of secukinumab in patients with hidradenitis suppurativa: Our clinical experience
Melgosa Ramos, Francisco Javier
Garcia-Ruiz, Ramon
Sanchez-Martinez, Eva M.
Gegundez-Hernandez, Hector
Diaz Corpas, Tania
Perez Garcia, Pilar
Ferrando Roca, Francisco Jose
Zayas Gavila, Ana Isabel
Mateu-Puchades, Almudena
EXPERIMENTAL DERMATOLOGY, 2021, 30 : 79 - 80
[4] Effectiveness and safety of acitretin for the treatment of moderate to severe hidradenitis suppurativa, predictors of clinical response
Sanchez-Diaz, Manuel
Diaz-Calvillo, Pablo
Rodriguez-Pozo, Juan A.
Arias-Santiago, Salvador
Molina-Leyva, Alejandro
EXPERIMENTAL DERMATOLOGY, 2022, 31 : 103 - 103
[5] Secukinumab in bio-experienced patients with moderate-to-severe hidradenitis suppurativa from a single center: an observational retrospective study
Tran, Thuy M.
Akpala, Christeebella O.
Tran, Tung S.
Davis, Mark Denis P.
Baum, Christian L.
Alavi, Afsaneh
Wetter, David A.
Nguyen, Giang H.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
[6] Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study
Schwensen, J. F.
Clemmensen, A.
Sand, C.
Gniadecki, R.
Skov, L.
Zachariae, C.
Iversen, L.
Rasmussen, M.
Thomsen, S. F.
DERMATOLOGIC THERAPY, 2017, 30 (06)
[7] Effectiveness and Safety of Acitretin for the Treatment of Hidradenitis Suppurativa, Predictors of Clinical Response: A Cohort Study
Sanchez-Diaz, Manuel
Diaz-Calvillo, Pablo
Angel Rodriguez-Pozo, Juan
Arias-Santiago, Salvador
Molina-Leyva, Alejandro
DERMATOLOGY, 2023, 239 (01) : 52 - 59
[8] Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials
Zouboulis, Christos C.
Passeron, Thierry
Bastos, Pedro Mendes
Pariser, David
Offidani, Annamaria
Kasparek, Torben
Wozniak, Magdalena
Li, Xianjun
Uhlmann, Lorenz
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB160 - AB160
[9] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
Megna, Matteo
Di Costanzo, Luisa
Argenziano, Giuseppe
Balato, Anna
Colasanti, Paola
Cusano, Francesco
Galluccio, Antonia G.
Gambardella, Alessio
Lembo, Serena
Mozzillo, Raffaele
Di Luzio, Genoveffa Scotto
Fabbrocini, Gabriella
Balato, Nicola
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 855 - 861
[10] Secukinumab and concomitant antibiotic use in patients with moderate-to-severe hidradenitis suppurativa: Week 16 efficacy and safety results from the Phase 3 SUNSHINE and SUNRISE trials
Kokolakis, Georgios
Martorell, Antonio
Kerdel, Francisco
Bettoli, Vincenzo
Giamarellos-Bourboulis, Evangelos J.
Sinclair, Rodney
Kasparek, Torben
Li, Xianjun
Martinez, Angela Llobet
Uhlmann, Lorenz
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB85 - AB85

← 1 2 3 4 5 →